We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

CIPA 2021: Covid-19 IP waiver could lead to ‘legal uncertainty’

Intellectual Property Magazine

CIPA 2021: Covid-19 IP waiver could lead to ‘legal uncertainty’

If the Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver for Covid-19 vaccines comes at all, it needs to be “very, very carefully balanced” so not to bring uncertainty, so said Grünecker’s Markus Grammel.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, please enter your details below to log in.

Enter your email address to log in as a user on your corporate account.
Remember me on this computer

Not yet an i-law subscriber?

Devices

Request a trial Find out more